Development of novel influenza neuraminidase inhibitors is critical for preparedness against influenza outbreaks. Knowledge of the neuraminidase enzymatic mechanism and transition-state analogue ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current ...

2022 年 5 月 12 日，武汉大学病毒学国家重点实验室周海兵教授、蓝柯教授、吴叔文副教授合作在国际学术期刊 Cell Insight 发表题为 “ Discovery of Oseltamivir-Based Novel PROTACs as Degraders Targeting Neuraminidase to Combat H1N1 Influenza Virus ” ...

参考资料： Julia Lederhofer et al. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase. Immunity, 2024 ...

The impact of influenza infection is felt globally each year when the disease develops in approximately 20 percent of the world's population. In the United States, influenza infections occur in ...

These patients were identified on the basis of a positive rapid influenza diagnostic test and received antiviral treatment (baloxavir or neuraminidase inhibitor) at the discretion of each ...

InDevR's game-changing VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines BOULDER COLORADO (6/12/18) -- InDevR Inc.

Please use one of the following formats to cite this article in your essay, paper or report: APA Dutta, Sanchari Sinha Dutta. (2023, February 07). Study characterizes mutations in neuraminidase of ...

Consequently, the World Health Organization raised the level of alert for an influenza pandemic to 5 on Apr. 29, 2009. 1 Because many infected people are young, 2 the care of pregnant and lactating ...

Influenza vaccines contain the viral surface proteins hemagglutinin and neuraminidase. While up to now, the constantly changing hemagglutinin has been considered the main protective antigen ...

Conclusions: Oseltamivir administered daily for six weeks by the oral route is safe and effective for the prevention of influenza. Context: The neuraminidase inhibitor zanamivir, a sialic acid ...